Although surgical resection is recommended for all
Introduction
Recently, many benign and low-grade malignant pancreatic lesions, including intraductal papillary-mucinous neoplasms (IPMNs), have been detected as a result of improvements in diagnostic modalities.
IPMNs have been defined and classified by the World Health
Organization and distinguished from other mucin-producing cystic neoplasms of the pancreas. 1 IPMNs are characterized by the dilatation of the pancreatic ducts, mucin hypersecretion and the papillary epithelial component. [2] [3] [4] IPMNs are classified into 2 types according to their site of occurrence: the main duct-type and branch duct-type. 2 IPMNs have a wide spectrum of histological findings, ranging from hyperplasia to adenoma to noninvasive or invasive carcinoma. 5 In addition, IPMN show a more favorable prognosis than typical pancreatic carcinomas. 6 The rate of the malignancy of the branch duct IPMNs is low, whereas main duct IPMNs are frequently malignant. [7] [8] [9] The average frequency of malignancy in main duct IPMNs based on several reports is 70%. 10 Therefore, the current treatment recommendation is that all main duct IPMNs should be considered candidates for resection. 2, 3 On the other hand, several controversies remain over T. Kuroki et al.
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the surgical strategy for main pancreatic duct-type IPMNs. Several reports have demonstrated that total pancreatectomy (TP) should be selected to achieve a full cure in patients with main duct IPMNs in which the main pancreatic duct shows diffuse dilatation to the whole pancreas. 11, 12 However, the dilatation of the main pancreatic duct to the whole pancreas might occur through the production of large amounts of mucin and/or associated chronic pancreatitis. 13 On the other hand, care must be taken when adapting the TP for IPMN, since TP causes severe and permanent pancreatic endocrine/exocrine insufficiency, and IPMNs are slow-growing and have a relatively favorable prognosis even when malignant. 14, 15 In this study, we evaluated the surgical strategy for the main duct-type IPMN of the pancreas. by the Japan Pancreatic Society. 17 Intraoperative frozen section analysis of the pancreas cut surface was performed routinely. When the resection margin was diagnosed as positive, an additional pancreatic resection of the remnant pancreas was carried out to achieve a negative margin.
Patients and methods
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Results
Clinical characteristics
The characteristics of all patients in this study are listed in Table 1 . The mean age was 68.5 years. There were 29 males and 17 females. Regarding clinical symptoms, 29 patients were asymptomatic and 17 patients had symptoms including abdominal pain (n=12), jaundice (n=2), loss of weight (n=2), and back pain (n=1).
Results of the OGTTT were normal in 26 patients, and indicated impairment or diabetes in 20 patients. The mean HbA1c level was 6.3%, and the mean BT-PABA test score was 57.1%.
Operative characteristics
The operative characteristics are listed in Table 2 . The maximum diameter of the main pancreatic duct was < 10 mm in 22 patients, and was ≧ 10 mm in 24 patients. In 20 patients, no mural nodule was detected, while a mural nodule of < 10 mm was detected in 9 patients, and a mural nodule of ≧ 10 mm was seen in 17 patients. Postoperative histology revealed that 17 patients had benign IPMNs, which were either adenomas (n=11), or a borderline lesion (n=6). Of the 46 patients, 29 (63%) showed malignant IPMNs; these cases consisted of non-invasive carcinomas (n=13), minimally invasive carcinomas (n=8), and invasive carcinomas (n=8).
Repeated pancreatectomy(Table 3)
Among the patients who underwent pancreatic surgery, 3
patients underwent repeated pancreatectomy. Among these 3 patients, TP was performed after DP in 2 cases and after PPPD in Two of these patients died of colon cancer, and the remaining patient died of the rupture of pseudoaneurysm due to the pancreatic fistula one month after surgery (Table 4) .
Discussion
The incidence of malignancy in main duct IPMNs is high. [7] [8] [9] [10] Therefore, the recommended management of main duct IPMNs is surgical resection according to the international consensus guideline for the management of IPMNs. 2 IPMNs tend to show a longitudinal wide spreading into the pancreatic duct. Okada et al. 18 reported that the distance of tumor spread in the main pancreatic duct was 41.6 ± 30.0 mm. On the other hand, dilatation of the main duct IPMN may be related to not only a neoplasm spread widely along the main pancreatic duct, but also to the overproduction of mucus and/or associated chronic pancreatitis. to avoid tumor-cell seeding during these surgical procedures.
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In conclusion, the routine performance of total pancreatectomy for the treatment of main duct IPMNs is not acceptable. Although total pancreatectomy has the potential to improve the long-term prognosis for patients with main duct IPMNs, it can also lead to severe and permanent endocrine and exocrine pancreatic insufficiency. We believe that it is important to perform sufficient and appropriate pancreatic resection for malignant lesions of main duct IPMN and to perform meticulous screening for the remnant pancreas following the initial pancreatic resection.
